login
login

Europe Daily Bulletin No. 12773

31 July 2021
EU RESPONSE TO COVID-19 / Health
EMA approves increase in production capacity of Moderna’s Covid-19 vaccine and predicts “significant impact” for EU
Brussels, 30/07/2021 (Agence Europe)

The European Medicines Agency (EMA) announced on Friday 30 July that it had approved “a scale-up of the active substance production process” of the Covid-19 vaccine Spikevax, developed by the company Moderna.

This “scale-up”—which does not require European Commission approval—involves two US vaccine manufacturing sites: ModernaTX, Inc. in Norwood, Massachusetts, and Lonza Biologics, Inc. in Portsmouth, New Hampshire.

The EMA’s recommendation is intended to confirm that both...

Contents

BEACONS
EU RESPONSE TO COVID-19
ECONOMY - FINANCE
SECTORAL POLICIES
EXTERNAL ACTION
COURT OF JUSTICE OF THE EU
NEWS BRIEFS